Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medivation Inc.

Division of Pfizer Inc.
www.medivation.com

Latest From Bukwang Pharmaceutical Co. Ltd.

Melior, Bukwang Seek Diabetes Edge With Novel Insulin Sensitizer

MLR-1023, a repositioned oral compound being developed for type 2 diabetes by Melior and Bukwang, is set to move into Phase IIb in the US and South Korea, and the firms are looking to its novel mechanism of action, improved tolerability and efficacy to carve a niche in a highly competitive sector.

Research & Development Diabetic Care

VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others

Gene editing is all the rage in biotechnology these days, but Caribou Biosciences Inc. has taken a different path than its CRISPR peers by diversifying beyond therapeutics to agriculture, industrial and applied research. The company also has taken a different financing path – recently closing a $30m Series B venture capital round instead of pursuing an initial public offering.

Companies Business Strategies

Korean Biotechs Relaunching IPOs After Withdrawals Last Year

South Korean companies that withdrew IPO plans late last year due largely to the crowded year-end offering market are now returning. Among them are drug developers Anterogen and Qurient, which successfully relaunched floats in the second-tier Kosdaq market in February.

BioPharmaceutical Asia Pacific

PharmAsia News business bulletin

A new regular roundup of commercial stories appearing in Scrip's sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace.

Infectious Diseases Orthopedics
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • David T Hung, MD, Pres. & CEO
    Jennifer Jarrett, CFO
    Joseph Lobacki, Chief Commercial Officer
    Marion McCourt, COO
  • Contact Info
  • Medivation Inc.
    Phone: (415) 543-3470
    525 Market St.
    36th Fl.
    San Francisco, CA 94105
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register